Geert Vanden Bossche's concerns point to a possible alternate to a 'leaky' vaccine. By tailoring antibodies to one strain that outcompete nonspecific antibodies he thinks it's possible to generate more virulent mutations that spread through the vaccinated population
Geert Vanden Bossche's concerns point to a possible alternate to a 'leaky' vaccine. By tailoring antibodies to one strain that outcompete nonspecific antibodies he thinks it's possible to generate more virulent mutations that spread through the vaccinated population